NA
TECX

Nordwand Advisors’s Tectonic Therapeutic TECX Stock Holding History

Nordwand Advisors’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,500
Closed -$26.6K – 223
2025
Q1 		$26.6K Hold
1,500
– – 0.01% 61
2024
Q4 		$69.3K Hold
1,500
– – 0.03% 41
2024
Q3 		$45.5K Buy
+1,500
New +$27.4K 0.01% 53

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Nordwand Advisors's TECX Position: Q2 2025 in Review

Nordwand Advisors sold out of Tectonic Therapeutic (TECX) in Q2 2025, closing a stake of 1,500 shares — an estimated $26.6K sold.

Nordwand Advisors first reported a position in TECX in Q3 2024 and held it in 3 quarters. The position peaked at $69.3K in Q4 2024. 82 funds tracked by Wall St. Rank hold TECX as of Q2 2025.

  • Nordwand Advisors reported no remaining Tectonic Therapeutic position as of Q2 2025 after selling out during the quarter.
  • Nordwand Advisors sold 1,500 Tectonic Therapeutic shares in Q2 2025, an estimated $26.6K.
  • Nordwand Advisors first reported a position in Tectonic Therapeutic in Q3 2024 and held it in 3 quarters.
  • Nordwand Advisors's Tectonic Therapeutic position peaked at $69.3K in Q4 2024.
  • 82 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2025.

Based on Nordwand Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.